| Retinal Vascular Disease Agents |
Beovu (brolucizumab), Eylea (aflibercept), Eylea HD (aflibercept), Lucentis 0.3 mg (ranibizumab), Cimerli 0.3mg (ranibizumab-eqrn), Nufymco (ranibizumab-leyk) 0.3mg, Lucentis 0.5mg (ranibizumab), Byooviz (ranibizumab-nuna), Cimerli 0.5mg (ranibizumab-eqrn), Nufymco (ranibizumab-leyk) 0.5mg, Pavblu (aflibercept-ayyh),Yesafili (aflibercept-jbvf), Susvimo (ranibizumab), Vabysmo (faricimab-svoa) |
| Revcovi (elapegademase-IvIr) |
Revcovi (elapegademase-IvIr) |
| Revlimid (lenalidomide) |
Revlimid (lenalidomide) |
| Revuforj (revumenib) |
Revuforj (revumenib) |
| Reyvow (lasmiditan) - PA, NF |
Reyvow (lasmiditan) |
| Rezdiffra (resmetirom) - PA, NF |
Rezdiffra (resmetirom) |
| Rezlidhia (olutasidenib) - PA, NF |
Rezlidhia (olutasidenib) |
| Rezurock (belumosudil) - PA, NF, QL |
Rezurock (belumosudil) |
| Rezzayo (rezafungin) |
Rezzayo (rezafungin) |
| Rhapsido (remibrutinib) |
Rhapsido (remibrutinib) |
| Riluzole Products |
Tiglutik (riluzole suspension), Teglutik (riluzole suspension) |
| Rinvoq (upadacitinib) |
Rinvoq (upadacitinib) ER tablets, Rinvoq LQ (upadacitinib) oral solution, Rinvoq (upadacitinib) extended-release (ER) tablets |
| Rituxan Hycela (rituximab and hyaluronidase human) |
Rituxan Hycela (rituximab and hyaluronidase human) |
| Rituximab - PA, NF |
Riabni (rituximab-arrx), Rituxan (rituximab), Ruxience (rituximab-pvvr), Truxima (rituximab-abbs) |
| Romvimza (vimseltinib) |
Romvimza (vimseltinib) |
| Rozlytrek (entrectinib) |
Rozlytrek (entrectinib) |
| Rubraca (rucaparib) - PA, NF |
Rubraca (rucaparib) |
| Rydapt (midostaurin) |
Rydapt (midostaurin) capsules |
| Ryoncil (remestemcel-l-rknd) - PA, NF |
Ryoncil (remestemcel-L-rknd) |
| Ryplazim (plasminogen, human-tvmh) |
Ryplazim (plasminogen, human-tvmh) |
HEALTHY LIVING